These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21628494)

  • 21. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
    Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
    Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
    Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
    Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.
    Misawa K; Kanazawa T; Misawa Y; Imai A; Uehara T; Mochizuki D; Endo S; Takahashi G; Mineta H
    J Cancer Res Clin Oncol; 2013 May; 139(5):879-89. PubMed ID: 23420374
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
    Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.
    Choudhury JH; Ghosh SK
    PLoS One; 2015; 10(6):e0129808. PubMed ID: 26098903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum biomarkers for detection of head and neck squamous cell carcinoma.
    Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
    Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients.
    Liu Y; Zhou ZT; He QB; Jiang WW
    Med Oncol; 2012 Jun; 29(2):729-33. PubMed ID: 21516484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
    Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
    Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
    Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.
    Alsofyani AA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Elaimi A; Al-Qahtani MH; Abuzenadah AM; Dallol A
    J Appl Genet; 2017 Nov; 58(4):459-465. PubMed ID: 28812223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
    Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
    Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
    Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.